Company: NCEL
Filing Date: 2025-07-29
Form Type: F-4/A
Source: 0001213900-25-068765
Chunk: 89

Company: NewcelX Ltd.
Filing Date: 2025-07-29
Form: F-4/A
Chunk 89
---
 9, 2025, are counted as outstanding for computing the percentage of the individual or entity holding such options or warrants but are not counted as outstanding for computing the percentage of any other individual or entity. (2)Consists of (i) 8,493,734 NLS Common Shares, (ii) 189,012 NLS Common Shares held by Revel Family Ltd., and (iv) 189,012 NLS Common Shares issuable upon exercise of common warrants held by Revel Family Ltd. exercisable within 60 days of July 9, 2025, subject to a beneficial ownership limitation of 9.99%. Revel Family Ltd. is controlled by Michel Revel, its sole equity owner, who holds voting and dispositive power over the securities. The address of Revel Family Ltd. is 52 HaNasi Harishon Street, Rehovot, Israel, 7630242. (3)Consists of (i) 438,169 NLS Common Shares, (ii) 3,279 NLS Common Shares issuable upon exercise of options vested and exercisable within 60 days of July 9, 2025, (iii) 13,054 NLS Common Shares issuable upon exercise of common warrants exercisable within 60 days of July 9, 2025, (iv) 100,807 NLS Common Shares issuable upon exercise of common warrants exercisable within 60 days of July 9, 2025, subject to a beneficial ownership limitation of 9.99%, and (v) 1,925 NLS Common Shares issuable upon exercise of pre -fundedwarrants exercisable within 60 days of July 9, 2025, subject to a beneficial ownership limitation of 4.99%. The beneficial ownership limitation restricts from exercising that portion of the warrants that would result in Mr. Ronald Hafner owning, after exercise, a number of NLS Common Shares in excess of the beneficial ownership limitation. Mr. Hafner is Chairman of NLS Pharmaceutics Ltd. (4)Consists of (i) 2,053,038 NLS Common Shares, (ii) 266,614 Common Shares issuable upon vesting of RSUs and exercisable within 60 days of July 9, 2025, and (iii) 457,828 NLS Common Shares issuable upon exercise of options vested and exercisable within 60 days of July 9, 2025